Fintel reports that on October 22, 2024, Susquehanna initiated coverage of BKV (NYSE:BKV) with a Positive recommendation.

Fintel reports that on October 21, 2024, Mizuho initiated coverage of BKV (NYSE:BKV) with a Outperform recommendation. What ...

Susquehanna initiated coverage of BKV Corp. (BKV) with a Positive rating and $24 price target BKV is unique in the exploration and production ...

KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 per share. BKV stands out due to its dual business model, which integrates ...

KeyBanc initiated coverage of BKV Corp. (BKV) with an Overweight rating and $23 price target BKV is primarily a natural gas-focused ...

Craig Cohen is the executive producer and host of Houston Matters, which airs weekday mornings at 9:00 on Houston Public ...

Patients receiving a kidney transplant and who are positive for BK virus (BKV) are at risk of losing their transplant due to BKV reactivation. At this time, there are no antiviral options available ...

DENVER, September 27, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per ...

DENVER, September 25, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") today announced the pricing of its initial public ...

Minnesota cities seek voter approval for local sales taxes to fund community centers, with Chanhassen proposing a $79.7M ...

Sept 26 (Reuters) - Shares of BKV (BKV.N), opens new tab rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.